Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

ATXG

Addentax Group Corp

Feb 12 • 04:00PM ET

0.3846

-0.0102 -2.60 %

Industrials • Integrated Freight & Logistics • China • NASD

Feb 12, 9:30 AMAddentax Group Corp. announces it is in advanced talks with a major Bitcoin investor to collaborate on a sovereign‑aligned, fully reserve‑backed stablecoin initiative in Southeast Asia tied to its plan to pursue up to 12,000 Bitcoins.

Peers: DAVA LDOS IDT CYRX VNET IIIV CNDT HASI OPI

Index	-	P/E	-	EPS (ttm)	-0.60	Insider Own	2.72%	Shs Outstand	11.72M	Perf Week	10.07%
Market Cap	4.51M	Forward P/E	-	EPS next Y	-	Insider Trans	-6.75%	Shs Float	11.40M	Perf Month	-10.04%
Enterprise Value	-12.81M	PEG	-	EPS next Q	-	Inst Own	1.42%	Short Float	0.01%	Perf Quarter	-16.12%
Income	-3.65M	P/S	1.19	EPS this Y	-	Inst Trans	-13.08%	Short Ratio	0.00	Perf Half Y	-16.70%
Sales	3.79M	P/B	0.17	EPS next Y	-	ROA	-11.10%	Short Interest	0.00M	Perf YTD	-1.94%
Book/sh	2.21	P/C	0.25	EPS next 5Y	-	ROE	-17.27%	52W High	1.86 -79.32%	Perf Year	-64.25%
Cash/sh	1.53	P/FCF	-	EPS past 3/5Y	- -17.05%	ROIC	-14.10%	52W Low	0.28 39.25%	Perf 3Y	-97.11%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-30.93% -16.29%	Gross Margin	8.82%	Volatility	43.02% 20.22%	Perf 5Y	-99.45%
Dividend TTM	-	EV/Sales	-3.38	EPS Y/Y TTM	31.50%	Oper. Margin	-56.57%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	23.99	Sales Y/Y TTM	-23.56%	Profit Margin	-96.22%	RSI (14)	50.33	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	24.34	EPS Q/Q	90.27%	SMA20	5.34%	Beta	2.19	Target Price	-
Payout	-	Debt/Eq	0.02	Sales Q/Q	-38.82%	SMA50	-6.40%	Rel Volume	0.43	Prev Close	0.39
Employees	112	LT Debt/Eq	0.00	Earnings	-	SMA200	-35.70%	Avg Volume	679.17K	Price	0.38
IPO	Dec 12, 2016	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	300,749	Change	-2.60%

Feb-12-26 09:25AM	Addentax Group Corp. Advances Sovereign-Aligned Stablecoin Initiative in Southeast Asia with Strategic Bitcoin Investor, Within Plan to Pursue up to 12,000 Bitcoins Acquistion (PR Newswire)
Feb-11-26 09:25AM	Addentax Group Corp. Announces Proposed Acquisition of Leading Asian AI-Enabled Hong Kong-based Licensed Digital Lending Platform, with Over HK$2 Billion Annual Loan Volume (PR Newswire) -7.96%
Feb-10-26 09:25AM	Addentax Group Corp. Entered Into Memorandum of Understanding for Potential US$200 Million Strategic Investment with Middle East Royal-Backed Institutional Investors at Proposed Price of $1.50 per Share, Supporting AI and Crypto Strategy (PR Newswire)
Feb-06-26 09:20AM	Addentax Group Corp. Announces Proposed Acquisition of Artificial Intelligence (AI)-empowered and Crypto-enabled Asset Management Platform, with Potential to Generate Approximately HKD 300 Million in Revenue (PR Newswire) -5.84%
Oct-14-25 09:25AM	Addentax Group Corp. Announces Strategic Cooperation Discussions with KINGS UNITED to Advance Web3.0 and RWA Initiatives (PR Newswire)
09:20AM	Loading…
Jul-02-25 09:20AM	Addentax Group Corp. Enters Into US$1.3 Billion Term Sheet for Proposed Acquisition of Up to 12,000 Bitcoins (PR Newswire) -11.56%
May-21-25 10:00AM	Chinese Firms Plan to Avoid Stock Delisting: Buy Trumps Memecoin (The Wall Street Journal) -9.77%
May-15-25 09:20AM	Addentax Group Corp. Announces $800 Million Plan to Acquire Bitcoin (BTC) and Official Trump (TRUMP) (PR Newswire) -6.75%
Mar-03-25 09:00AM	Addentax Group Corp. Regains Compliance with Nasdaq's Minimum Bid Price Requirement (PR Newswire) +5.58%
Jan-13-25 09:00AM	Addentax Invests Equity Stake in Fresh Food Marketing Solution Provider, Well Information Technology Corporation (PR Newswire) -5.27%
Nov-21-24 09:16AM	Addentax Group Corp. Announces Signing of MOU for Strategic Cooperation with Shenzhen Yingbin Brand Development Co., Ltd. (PR Newswire)
Apr-29-24 11:50AM	Addentax Group Corp. Announces Private Placements of its Common Stock (PR Newswire) +9.23%
Mar-20-24 09:45AM	Addentax Group Corp. and Dezhong Xinghui Collaborate to Develop AI Logistic System, Facilitating Breakthroughs in Logistics Delivery (PR Newswire)
Mar-05-24 09:45AM	Addentax Group Corp. and Regina Miracle International (Holdings) Limited Entered into a Collaboration Agreement to Enhance Textile and Garment Industry Services (PR Newswire)
Feb-06-24 09:45AM	Addentax Group Corp. is Launching 'Tourism-As-A-Service' Platform with Artificial Intelligence and Block-Chain Tools to Incubate Local and Overseas Pan-Entertainment and Tourism Services (PR Newswire)
09:00AM	Loading…
Dec-22-23 09:00AM	Addentax Group Corp. Announces Signing of MOU for Strategic Cooperation with Zhongjiu Yihe (PR Newswire) -11.74%
Oct-18-23 09:45AM	Addentax Group Corp. Elevates Artificial Intelligence Content Creation Through Innovative R&D Collaboration with Xi'an University of Electronic Science and Technology (PR Newswire) -7.64%
Sep-05-23 09:45AM	Addentax Group Corp. Launches Strategic Negotiations with Xianglilai for Advanced Lithium Battery Integration in Logistics and Autonomous New Energy Vehicles (PR Newswire) -5.91%
Aug-29-23 12:00PM	Addentax Group Corp. Regains Compliance with Nasdaq Minimum Bid Price Requirement (PR Newswire)
Aug-15-23 09:45AM	Addentax Group Corp. Continues to Make Significant Strides in Advancing the Automation of Artificial Intelligence Internet Operational Tools (PR Newswire) -10.00%
Jul-25-23 09:15AM	Addentax Group Corp. Launches a Metaverse Project with NFTCN-Bigverse, Bridging Blockchain, Internet Content, and Society through NFT Art Innovation (PR Newswire)
Jul-06-23 09:15AM	Addentax Group Corp. Leverages GW Reader Sdn Bhd 's AI Technology to Drive Next-Level Operational Excellence (PR Newswire) -8.91%
Jun-30-23 09:41AM	Addentax Group Corp. is Launching Automation of Artificial Intelligence Internet Operational Tools Project with Top Games-as-a-Service Firms (PR Newswire)
Jun-29-23 12:30PM	Addentax Group Corp. Announces 1-for-10 Reverse Share Split (PR Newswire) -9.72%
Jun-15-23 08:00AM	Addentax Group Corp. in Advanced Talks to Acquire Partial Stake in RMB 6 Billion-Valued Recombinant Protein Drugs and Antibody Drugs Bio-pharmaceutical Company, Shanghai Bao Pharmaceutical Company Limited (PR Newswire) +11.41%
Jun-08-23 08:00AM	Addentax Group Corp. Entered into a Service Agreement with SF Express for Logistics Services (PR Newswire)
Jun-06-23 08:00AM	Addentax Group Corp. Entered into a Strategic Cooperation Agreement with AUTO CITY for L4 Autopilot Tech, New Energy Autopilot Vehicles and EV Charging Research and Manufacturing (PR Newswire) +13.90%
May-02-23 09:35AM	Addentax Group Corp. Pursues Collaborations with Two Textile Companies in China for Digital Transformations and AI Advancements (PR Newswire) -7.89%
Apr-14-23 11:58AM	Addentax Group Corp. Initiates Task Force to Investigate Suspected Illegal Trading Activities (PR Newswire)
Jan-04-23 09:52AM	Addentax Group Corp. Announces Entry of a Securities Purchase Agreement (PR Newswire) +10.19%
05:30AM	Loading…
Oct-22-22 05:30AM	Nasdaq Freezes Chinese Small-Cap IPOs After Price Spikes (The Wall Street Journal)
Sep-02-22 10:51AM	Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Closing of $25 Million Public Offering of Common Stock (PR Newswire) -68.03%
Aug-30-22 04:40PM	Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $25 Million Public Offering of Common Stock (PR Newswire)

Addentax Group Corp. is a holding company, along with its subsidiaries, engages in the textile and garments industry. It operates through the following segments: Garment Manufacturing, Logistics Services, and Property Management and Subleasing. The Garments Manufacturing segment focuses on manufacturing and distribution of garments. The Logistics Services segment includes delivery and courier services covering some provinces in China. The Property Management and Subleasing segment offers services for wholesalers and retailers. The company was founded on October 28, 2014 and is headquartered in Shenzhen, China.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hamilton Alex P.	Director	Sep 08 '25	Sale	0.52	23,095	12,009	0	Nov 19 11:43 AM
Hamilton Alex P.	Director	Sep 02 '25	Proposed Sale	0.56	23,095	12,936		Sep 02 10:25 AM

Open in Screener

MGRX

Mangoceuticals Inc

Feb 12 • 04:00PM ET

0.3948

+0.0148 3.89 %

Healthcare • Health Information Services • USA • NASD

MGRX Mangoceuticals Inc daily Stock Chart

Peers: JNJ ABBV LLY PFE AZN-D MRK GILD BMY GSK BIIB

| Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-2.86	Insider Own	21.26%	Shs Outstand	13.88M	Perf Week	16.08%
Market Cap	6.43M	Forward P/E	-	EPS next Y	-	Insider Trans	-3.97%	Shs Float	12.83M	Perf Month	-44.08%
Enterprise Value	6.06M	PEG	-	EPS next Q	-	Inst Own	4.60%	Short Float	2.50%	Perf Quarter	-77.05%
Income	-19.82M	P/S	13.68	EPS this Y	-	Inst Trans	15.15%	Short Ratio	0.18	Perf Half Y	-76.78%
Sales	0.47M	P/B	0.35	EPS next Y	-	ROA	-125.56%	Short Interest	0.32M	Perf YTD	-46.65%
Book/sh	1.13	P/C	13.40	EPS next 5Y	-	ROE	-134.99%	52W High	6.15 -93.58%	Perf Year	-91.27%
Cash/sh	0.03	P/FCF	-	EPS past 3/5Y	-560.03% -	ROIC	-126.02%	52W Low	0.34 16.08%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-284.26%	Volatility	15.35% 16.91%	Perf 5Y	-
Dividend TTM	-	EV/Sales	12.89	EPS Y/Y TTM	50.05%	Oper. Margin	-4297.16%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.74	Sales Y/Y TTM	-38.16%	Profit Margin	-4245.33%	RSI (14)	34.96	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.74	EPS Q/Q	33.40%	SMA20	-12.41%	Beta	2.53	Target Price	-
Payout	-	Debt/Eq	0.01	Sales Q/Q	-36.83%	SMA50	-47.30%	Rel Volume	0.16	Prev Close	0.38
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	-75.21%	Avg Volume	1.79M	Price	0.39
IPO	Mar 21, 2023	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	279,498	Change	3.89%

Dec-19-25 12:32PM	Big Move In Solana: 2 Reasons Why This Top Token Surged 7% Off Yesterday's Bottom (Motley Fool) -45.57%
10:38AM	Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements (GlobeNewswire)
07:30AM	Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy (GlobeNewswire)
Dec-18-25 08:30AM	Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules (GlobeNewswire) +7.38%
Nov-14-25 08:00AM	Eli Lilly and Novo Nordisk disown Mangoceuticals GLP-1RA partnership claim (Pharmaceutical Technology) +24.37%
07:37PM	Loading…
Nov-13-25 07:37PM	Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs (GlobeNewswire) -32.39%
07:00AM	Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management (GlobeNewswire)
May-28-25 09:15AM	Mangoceuticals shares results from field studies on MGX-0024 (TipRanks) +11.64%
May-27-25 09:00AM	Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu (GlobeNewswire) +11.83%
Apr-28-25 05:36AM	ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market (Newsfile)
Apr-25-25 09:00AM	Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division (GlobeNewswire) -13.81%
Apr-22-25 01:55PM	CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape (ACCESSWIRE) -10.04%
Mar-25-25 09:00AM	Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol in the USA and Canada (GlobeNewswire) -40.84%
Feb-20-25 07:00AM	Mangoceuticals Announces the Launch of PeachesRx - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments (GlobeNewswire) -15.71%
Feb-12-25 08:00AM	Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution (GlobeNewswire)
07:00AM	Loading…
Feb-06-25 07:00AM	Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research (GlobeNewswire) +7.89%
Feb-03-25 08:30AM	Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation (GlobeNewswire)
Dec-19-24 05:33PM	Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent (GlobeNewswire)
Dec-04-24 07:00AM	Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split (GlobeNewswire)
Oct-31-24 08:00AM	Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Oct-22-24 08:00AM	MangoRx Announces Formation of Strategy and Alternatives Committee (GlobeNewswire)
Oct-21-24 05:10PM	MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly (GlobeNewswire)
Oct-18-24 08:45AM	Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 (Newsfile)
Oct-12-24 05:20PM	Mangoceuticals announces 1-for-15 reverse stock split (TipRanks)
Oct-11-24 05:15PM	MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN (GlobeNewswire) -10.68%
Oct-03-24 08:30AM	MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions (GlobeNewswire) -11.27%
Oct-01-24 07:30AM	MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment (GlobeNewswire) +26.44%
Aug-15-24 09:25AM	MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024 (GlobeNewswire)
Aug-13-24 04:00PM	MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent (GlobeNewswire) +9.61%
Aug-09-24 08:15AM	MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide (GlobeNewswire) -13.96%
08:30AM	Loading…
Aug-08-24 08:30AM	MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market (ACCESSWIRE)
Jul-25-24 06:00AM	Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future (News Direct)
Jul-24-24 08:15AM	MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology (GlobeNewswire)
Jul-18-24 04:05PM	Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access (GlobeNewswire) -8.04%
Jul-16-24 08:20AM	MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts (GlobeNewswire) +11.46%
Jul-12-24 01:30PM	MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department (GlobeNewswire) +7.25%
Jul-11-24 08:15AM	MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets (GlobeNewswire) +6.45%
Jun-06-24 08:30AM	MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology (GlobeNewswire)
Jun-04-24 04:00PM	MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies (GlobeNewswire) +6.00% +6.87%
08:00AM	MangoRx to Introduce MOJO Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances (GlobeNewswire)
May-28-24 08:30AM	Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets (GlobeNewswire) +7.00%
07:27AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-23-24 09:45AM	MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts (ACCESSWIRE) +13.04%
May-22-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -10.73%
May-21-24 04:00PM	Why Is Mangoceuticals (MGRX) Stock Up 130% Today? (InvestorPlace) +103.68%
08:30AM	MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications (GlobeNewswire)
May-16-24 09:53PM	MGRX Stock Earnings: Mangoceuticals Reported Results for Q1 2024 (InvestorPlace) +9.50%
04:40PM	MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration (GlobeNewswire)
May-02-24 08:00AM	Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement (GlobeNewswire)
Apr-25-24 08:30AM	Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care (GlobeNewswire)
Apr-12-24 08:45AM	Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products (GlobeNewswire) -9.93%
Mar-12-24 09:00AM	MangoRx Officially Launches 'PRIME' by MangoRx, Powered by Kyzatrex FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment (GlobeNewswire)
Feb-20-24 09:00AM	MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth (GlobeNewswire)
Feb-13-24 08:00AM	MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY (GlobeNewswire) -13.39%
Feb-06-24 09:00AM	MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE SPIRITS (GlobeNewswire) +6.51%
Feb-05-24 08:50AM	MangoRx Accepting Pre Orders for its PRIME , by MangoRx, Powered by Kyzatrex FDA Approved Oral Testosterone Replacement Therapy (TRT) Product (GlobeNewswire) -7.01%
Jan-19-24 08:00AM	MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11 (GlobeNewswire)
Dec-15-23 10:39AM	Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering (GlobeNewswire) -40.97%
09:29AM	Why Is Mangoceuticals (MGRX) Stock Down 33% Today? (InvestorPlace)
Dec-13-23 07:30AM	MANGOCEUTICALS TO INTRODUCE PRIME , POWERED BY KYZATREX (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT (GlobeNewswire)
Dec-06-23 08:00AM	Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America (GlobeNewswire)
Nov-29-23 08:30AM	Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider (GlobeNewswire) +17.61%
Nov-16-23 08:30AM	Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx (ACCESSWIRE)
Nov-02-23 09:15AM	Mangoceuticals, Inc. Launches Charitable Initiative in Support of Men's Health Awareness Month (GlobeNewswire) -10.75%
Oct-26-23 07:30AM	Mangoceuticals Launches TikTok Influencer Initiative and Becomes the Presenting Sponsor of the Only Stans Podcast with Glenny Balls (GlobeNewswire) +8.57%
Oct-19-23 09:00AM	Mangoceuticals, Inc. Provides Update to Shareholders on Q3 Achievements and Guidance on Year End and Near-Term Initiatives (GlobeNewswire) +25.00%
Oct-13-23 09:40AM	Mangoceuticals Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Bloomberg TV and Fox Business (GlobeNewswire)
09:12AM	New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network (GlobeNewswire)
Oct-12-23 09:15AM	Mangoceuticals Announces the Official Launch of MangoRx Affiliate Marketing Program to Enhance and Accelerate Topline Growth (GlobeNewswire) -8.03%
Sep-14-23 06:00AM	Mangoceuticals Brand MangoRx Announced as Raindance Film Festivals Headline Sponsor (GlobeNewswire)
Sep-08-23 10:38AM	UPDATE: New to The Street Proudly Announces its 500th Special Edition 1-hour Broadcast with Guest Appearances, Airs on Newsmax, Saturday, September 9, 2023, 3:00-4:00 PM ET (GlobeNewswire) +5.30%
09:30AM	New to The Street Proudly Announces its 500th Special Edition 1-hour Broadcast with Guest Appearances, Airs on Newsmax, Saturday, September 9, 2023, 3:30 PM ET (GlobeNewswire)
Sep-07-23 08:00AM	Mangoceuticals Expands its Nationwide Marketing Efforts with a Multiplatform Audio Powerhouse Across America (GlobeNewswire)
Aug-30-23 08:00AM	Mangoceuticals Launches New High-Production Quality Ad Providing Fresh Insight into its Proprietary Mango Erectile Dysfunction Pill Formula (GlobeNewswire)
Aug-16-23 08:00AM	Mangoceuticals Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve (GlobeNewswire)
Aug-09-23 08:00AM	Mangoceuticals Partners with Greater NY Chamber of Commerce for Mass Marketing & Sales of Flagship Mango Product (GlobeNewswire)
Aug-02-23 08:00AM	Mangoceuticals, Inc. Names Award Winning Globally Recognized Lucky Break PR as Public Relations Firm (GlobeNewswire)
Aug-01-23 08:00AM	Mangoceuticals Engages Premier Global Software Development Firm, RedLime Solutions to Expand Technology Platform to Accommodate Increased Customer Flow (GlobeNewswire) +28.32%
Jul-27-23 08:00AM	Mangoceuticals, Inc. Adds Top Mens Podcast, Pillow Talk with Ryan Pownall, to Sponsorship Portfolio (GlobeNewswire) -5.17%
Jul-24-23 10:47AM	New to The Street TV Announces Episode 491 with its Five Business Guest Interviews, Airs on FOX Business Network, Tonight, July 24, 2023, at 10:30 PM PT (GlobeNewswire) -7.17%
Jul-21-23 09:30AM	New to The Street Announces its Five Corporate Interviews, Episode 490, Airing on Newsmax, Saturday, July 22, 2023, at 3:30 PM ET (GlobeNewswire)
Jul-18-23 10:00AM	Mangoceuticals Engaged by Social Media Sensation Adam22 as Exclusive New Sponsor of Hit Podcasts with Skyrocketing Male Engagement (GlobeNewswire)
Jul-12-23 10:00AM	Mangoceuticals, Inc. Announces TV Air Dates for Interview Featuring CEO Jacob Cohen on Fox Business, Bloomberg TV, and Newsmax TV (GlobeNewswire)
Jun-29-23 10:00AM	Mangoceuticals Collaborates with Ice Shaker to Launch Mango Branded Ice Shaker Protein Bottles on MakeAmericaHardAgain.com (ACCESSWIRE)
Jun-27-23 10:00AM	Mangoceuticals Launches Make America Hard Again Campaign & Merchandise Website (GlobeNewswire) -5.43%
Jun-22-23 10:30AM	Mangoceuticals CEO to Feature in Upcoming Interview at Nasdaq MarketSite Studio on Fox Business, Bloomberg TV, and Newsmax TV (GlobeNewswire) +9.94%
Jun-21-23 08:00AM	Mangoceuticals, Inc. Announces Upcoming Launch of its Sildenafil Based Mango Flavored Rapid Dissolve ED Product (GlobeNewswire)
Jun-15-23 09:00AM	Mangoceuticals, Inc. Signs Sponsorship Agreement with GaS Digital Network to Promote Mango Across Multiple Hardcore Comedy Podcasts (GlobeNewswire) -6.06%
Jun-08-23 09:00AM	Mangoceuticals Signs Deal with BarStool Sports to Market Mango on Popular Only Stans Podcast (GlobeNewswire) +10.81%
Jun-07-23 11:36PM	Mangoceuticals Inc. (NASDAQ: MGRX) and the Booming Men's Health Market (News Direct) -9.20%
May-25-23 10:00AM	Mangoceuticals Adds Renowned Tech Entrepreneur and Investor, Aaron Andrew, to Advisory Board (GlobeNewswire)
May-18-23 09:15AM	Mangoceuticals to Ring NASDAQ Stock Market Closing Bell on May 18 (GlobeNewswire)
May-11-23 09:45AM	Mangoceuticals Launches New Some Things Are Better Hard Viral Video Ad Campaign (GlobeNewswire)
May-04-23 09:30AM	Mangoceuticals, Inc. Appoints Amanda Hammer as New Chief Operating Officer (ACCESSWIRE)
Apr-25-23 09:35AM	Mangoceuticals, Inc. (MGRX) Commences Online Direct Sales Campaign Utilizing DataDojo AI and Customer Data Platform (CDP) (ACCESSWIRE) -7.69%
Apr-20-23 09:00AM	Mangoceuticals, Inc. Now Featured on Webull Corporate Communications Service Platform (ACCESSWIRE)
Apr-18-23 09:15AM	Mangoceuticals, Inc.'s Debut Commercial Surpasses 5 Million Views on YouTube (ACCESSWIRE) -9.99%
Mar-30-23 09:00AM	Mangoceuticals, Inc. Retains ShareIntel - Shareholder Intelligence Services (ACCESSWIRE) -22.87%
Mar-23-23 04:30PM	Mangoceuticals, Inc. Announces Closing of $5 Million Initial Public Offering (ACCESSWIRE) -20.66%
Mar-21-23 10:00AM	Mangoceuticals, Inc. Announces Pricing of Initial Public Offering (ACCESSWIRE)

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JOHNSTON EUGENE M	CFO	Dec 15 '25	Sale	1.17	3,333	3,884	120,000	Dec 17 05:00 PM
JOHNSTON EUGENE M	CFO	Dec 09 '25	Sale	1.20	5,000	5,975	123,333	Dec 11 04:05 PM
JOHNSTON EUGENE M	CFO	Dec 05 '25	Sale	1.13	10,000	11,280	128,333	Dec 09 05:16 PM
JOHNSTON EUGENE M	Officer	Dec 03 '25	Proposed Sale	1.16	128,333	148,866		Dec 03 10:03 AM
Hamilton Alex P.	Director	Nov 19 '25	Sale	1.22	125,000	152,875	3,334	Nov 26 04:30 PM
Hamilton Alex P.	Director	Nov 19 '25	Proposed Sale	1.24	125,000	155,125		Nov 19 11:46 AM

ATXG

Addentax Group Corp

MGRX

Mangoceuticals Inc

Upgrade your FINVIZ experience